Ipodate treatment of hyperthyroidism in cats

Journal of the American Veterinary Medical Association

Volumn 211, Issue 1, 1997, Pages 63-67

  Murray, Louise A S ^a   Peterson, Mark E ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOPODIC ACID; LIOTHYRONINE; THIAMAZOLE; THYROXINE;

ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CAT DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HYPERTHYROIDISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; THYROID DISEASE; THYROID FUNCTION TEST; TREATMENT OUTCOME;

ANIMALS; CAT DISEASES; CATS; CONTRAST MEDIA; FEMALE; HEART RATE; HYPERTHYROIDISM; IPODATE; MALE; PROSPECTIVE STUDIES; THYROXINE; TRIIODOTHYRONINE;

ANIMALIA; FELIS CATUS;

EID: 0030811554     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Peterson ME. Hyperthyroid diseases. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. Philadelphia: WB Saunders Co, 1995; 1466-1487.
2. Peterson ME, Kintzer PP, Hurvitz AI. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988;2:150-157.
3. Wu SY, Shyh TP, Chopra IJ, et al. Comparison of sodium ipodate (Oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J Clin Endocrinol Metab 1982;54:630-634.
4. Shen DC, Wu SY, Chopra IJ, et al. Long term treatment of Graves' hyperthyroidism with sodium ipodate. J Clin Endocrinol Metab 1985;61:723-727.
5. Wu SY, Chopra IJ, Solomon DH, et al. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 1978;46:691-697.
6. Roti E, Gardini E, Minelli R, et al. Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. Metabolism 1993;42:403-408.
7. Burgi H, Wimpfheimer CC, Burger A, et al. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 1976;43:1203-1210.
8. Laurberg P. Multisite inhibition by ipodate of iodothyronine secretion from perfused dog thyroid lobes. Endocrinology 1985;117:1639-1644.
9. 3 in rat liver. Horm Metab Res 1980;12:685-687.
10. Chopra IJ, Huang TS, Hurd RE, et al. A study of cardiac effects of thyroid hormones: evidence for amelioration of the effects of thyroxine by sodium ipodate. Endocrinology 1984;114:2039-2045.
11. Zar JH. Multisample hypotheses: the analysis of variance. In: Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall Inc, 1984;162-184.
12. Glantz SA. The special case of two groups: the t-test. In: Primer of biostatistics. New York: McGraw-Hill Book Co, 1981;63-93.
13. Berk RN, Loeb PM, Cobo-Frenkel A, et al. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid. Invest Radiol 1977;12:85-95.
14. Hunter TB, Fon GT, Berk RN, et al. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs. Gastrointest Radiol 1981;6:349-352.
15. Rosati G, De Micheli P, Schiantarelli P. Pharmacologic properties of a new oral contrast medium for cholecystography. Acta Radiol Diagn 1972;12:335-346.
16. Beng CG, Wellby ML, Symons RG, et al. The effects of ipodate on the serum iodothyronine pattern in normal subjects. Acta Endocrinol 1980;93:175-178.
17. Wu SY, Chopra IJ, Solomon DH, et al. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J Clin Endocrinol Metab 1978;47:1358-1362.
18. Volpe R. Graves' disease. Pathogenesis. In: Braverman LE, Utiger R, eds. Werner's and Ingbar's the thyroid. Philadelphia: JB Lippincott Co, 1991;648-657.
19. Bal C, Nair N. The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism. J Nucl Med 1990;31:1180-1182.
20. Wang YS, Tsou CT, Lin WH, et al. Long-term treatment of Graves' disease with iopanoic acid (Telepaque). J Clin Endocrinol Metab 1987;65:679-682.
21. Martino E, Balzano S, Bartalena L, et al. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. J Endocrinol Invest 1991;14:847-851.
22. Sedgwick CJ, Pokras M, Kaufman G. Metabolic scaling: using estimated energy costs to extrapolate drug doses between different species and different individuals of diverse body sizes, in Proceedings. Am Assoc Zoo Vet Annu Meet 1990;249-254.
23. Gerber H, Peter H, Ferguson DC, et al. Etiopathology of feline toxic nodular goiter. Vet Clin North Am Small Anim Pract 1994;24:541-565.
24. Peterson ME, Livingston P, Brown RS. Lack of circulating thyroid stimulating immunoglobulins in cats with hyperthyroidism. Vet Immunol Immunopathol 1987;16:277-282.
25. Peter HJ, Gerber H, Studer H, et al. Autonomous growth and function of cultured thyroid follicles from cats with spontaneous hyperthyroidism. Thyroid 1991;1:331-338.